null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Hemophilia: Genes and Diseases

List Price: $85.00
SKU:
9781632422279
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Brian Jenkins
    Format:
    Hardcover
    Pages:
    142
    Publisher:
    FOSTER ACADEMICS (January 16, 2015)
    Language:
    English
    ISBN-13:
    9781632422279
    ISBN-10:
    1632422271
    Dimensions:
    5.98" x 9.02"
    File:
    TWO RIVERS-PERSEUS-Metadata_Only_Perseus_Distribution_Customer_Group_Metadata_20250917125235-20250918.xml
    Folder:
    TWO RIVERS
    List Price:
    $85.00
    Case Pack:
    44
    As low as:
    $73.95
    Publisher Identifier:
    P-PER
    Discount Code:
    F
    Pub Discount:
    45
    Weight:
    12.8oz
    Imprint:
    FOSTER ACADEMICS
  • Overview

    Hemophilia is a medical condition in which the clotting ability of blood is extensively reduced. The book reflects the significant endeavours aimed at enhancing caretaking methods for hemophilia patients. This will lead to advancements in the quality of life of hemophilic patients and their families.